AusBiotech

AusBiotech has launched the 2019 CEO Industry Position Survey, asking leaders of biotechnology companies for their views – the good, the bad and the ugly – of our Australian life sciences sector.

Following on from AusBiotech’s successful presentation of Australian life sciences at Biotech Showcase in San Francisco last week, we are already turning our attention to the next growth opportunity for our sector.

This year AusBiotech has seen defence of the critical RDTI, a number of gene technology relative to agriculture submissions, a change in leadership, a new strategic plan developed and launched, and a diversity and inclusion commitment – not to mention new guidance and reports, an online platform unveiling, a plethora of events delivered across the country and internationally, and new Industry Excellence Award winners.

AusBiotech has made a supportive submission to the TGA in response to its draft discussion paper on the future regulation of in vitro diagnostic companion diagnostics.

A new report was launched this week on ‘Digital health: Creating a new growth industry for Australia’, by ANDHealth, highlighting what is required to prosper a thriving, international digital health industry.

Clinical trials are a strength for the Australian life sciences sector, however the ongoing issues of fragmentation and inefficiency within our regulatory system impacts on Australia fulfilling its true capacity and capability.

The work of MTPConnect, Australia’s medical technologies and pharmaceuticals growth centre, is set to continue after new funding was announced by the Federal Government this week.

AusBiotech announced the appointment of Dr Dean Moss as a Director - an addition that brings strong global and commercialisation experience to the AusBiotech Board - and the departure of Lawrence Gozlan, at its Annual General Meeting.

This week the International Consortium of Investigative Journalists has launched The Implant Files: a global examination of the medical devices industry and its regulators.

AusBiotech is inviting session proposals for AusMedtech 2019. AusBiotech invites proposals for presentations, panels, workshops and technology showcases.

IP Australia has published a response to its consultation on draft legislation that includes measures to implement aspects of the Government’s response to the Productivity Commission’s (PC) inquiry into Australia’s IP arrangements.

AusBiotech has made a submission into a Senate Inquiry into the legislative Bill that includes the R&D Tax incentive (RDTI) reforms, urging the Inquiry to delay its passage until the impacts are better understood and can be mitigated.